CCA
AGN

Catalyst Capital Advisors’s Allergan Inc AGN Stock Holding History

Catalyst Capital Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1,500
Closed -$319K – 615
2014
Q4 		$319K Sell
1,500
-500
-25% -$99.4K 0.04% 273
2014
Q3 		$356K Sell
2,000
-2,000
-50% -$332K 0.05% 258
2014
Q2 		$677K Buy
+4,000
New +$623K 0.11% 207

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Catalyst Capital Advisors's AGN Position: Q1 2015 in Review

Catalyst Capital Advisors sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 1,500 shares — an estimated $319K sold.

Catalyst Capital Advisors first reported a position in AGN in Q2 2014 and held it in 3 quarters. The position peaked at $677K in Q2 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Catalyst Capital Advisors reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Catalyst Capital Advisors sold 1,500 Allergan Inc shares in Q1 2015, an estimated $319K.
  • Catalyst Capital Advisors first reported a position in Allergan Inc in Q2 2014 and held it in 3 quarters.
  • Catalyst Capital Advisors's Allergan Inc position peaked at $677K in Q2 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Catalyst Capital Advisors's 13F filing for Q1 2015, filed 15 May 2015.